Sareum Holdings PLC
SAR
ISIN GB00BMC3RJ87 / Valor 116566624
Sareum Holdings PLC
UMushroom community rating:
About company
Sareum Holdings PLC is a clinical-stage biopharmaceutical company focused on the development of small molecule kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research and development efforts are centered on creating next-generation therapies that target specific kinases involved in disease pathways, aiming to provide more effective and targeted treatment options. Sareum leverages its expertise in medicinal chemistry and drug discovery to advance its pipeline of therapeutic candidates through preclinical and clinical stages, with the goal of addressing unmet medical needs in oncology and immunology.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
28 M
Market cap (USD)
194,241
Daily traded volume (Shares)
0.27 / 0.27
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Lukas Mykhnenko
EQUITIES OF THE SAME SECTOR
